BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

363 related articles for article (PubMed ID: 17052294)

  • 1. Skeletal muscles in chronic obstructive pulmonary disease: deconditioning, or myopathy?
    Wagner PD
    Respirology; 2006 Nov; 11(6):681-6. PubMed ID: 17052294
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Polyunsaturated fatty acids improve exercise capacity in chronic obstructive pulmonary disease.
    Broekhuizen R; Wouters EF; Creutzberg EC; Weling-Scheepers CA; Schols AM
    Thorax; 2005 May; 60(5):376-82. PubMed ID: 15860712
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Exercise-induced systemic effects in muscle-wasted patients with COPD.
    Van Helvoort HA; Heijdra YF; Thijs HM; Viña J; Wanten GJ; Dekhuijzen PN
    Med Sci Sports Exerc; 2006 Sep; 38(9):1543-52. PubMed ID: 16960513
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Respiratory muscles in COPD: regulation of trophical status.
    Decramer M
    Verh K Acad Geneeskd Belg; 2001; 63(6):577-602; discussion 602-4. PubMed ID: 11813511
    [TBL] [Abstract][Full Text] [Related]  

  • 5. The potential anti-inflammatory effect of exercise in chronic obstructive pulmonary disease.
    van der Vlist J; Janssen TW
    Respiration; 2010; 79(2):160-74. PubMed ID: 19672044
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Skeletal muscle weakness, reduced exercise tolerance, and COPD: is systemic inflammation the missing link?
    Sin DD; Man SF
    Thorax; 2006 Jan; 61(1):1-3. PubMed ID: 16396949
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Systemic inflammation and skeletal muscle dysfunction in chronic obstructive pulmonary disease: state of the art and novel insights in regulation of muscle plasticity.
    Remels AH; Gosker HR; van der Velden J; Langen RC; Schols AM
    Clin Chest Med; 2007 Sep; 28(3):537-52, vi. PubMed ID: 17720042
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Markers of inflammation and disuse in vastus lateralis of chronic obstructive pulmonary disease patients.
    Crul T; Spruit MA; Gayan-Ramirez G; Quarck R; Gosselink R; Troosters T; Pitta F; Decramer M
    Eur J Clin Invest; 2007 Nov; 37(11):897-904. PubMed ID: 17883420
    [TBL] [Abstract][Full Text] [Related]  

  • 9. [Local exercise and oxidative stress in chronic obstructive broncho-pneumopathies: preliminary results].
    Couillard A; Cristol JP; Chanez P; Varray A; Maltais F; Préfaut C
    J Soc Biol; 2001; 195(4):419-25. PubMed ID: 11938559
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Therapeutic prospects to treat skeletal muscle wasting in COPD (chronic obstructive lung disease).
    Hansen MJ; Gualano RC; Bozinovski S; Vlahos R; Anderson GP
    Pharmacol Ther; 2006 Jan; 109(1-2):162-72. PubMed ID: 16154635
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Skeletal muscle response to inflammation--lessons for chronic obstructive pulmonary disease.
    Reid WD; Rurak J; Harris RL
    Crit Care Med; 2009 Oct; 37(10 Suppl):S372-83. PubMed ID: 20046123
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Increased serum inflammatory markers in the absence of clinical and skeletal muscle inflammation in patients with chronic obstructive pulmonary disease.
    Piehl-Aulin K; Jones I; Lindvall B; Magnuson A; Abdel-Halim SM
    Respiration; 2009; 78(2):191-6. PubMed ID: 19270439
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Hypogonadism, quadriceps weakness, and exercise intolerance in chronic obstructive pulmonary disease.
    Van Vliet M; Spruit MA; Verleden G; Kasran A; Van Herck E; Pitta F; Bouillon R; Decramer M
    Am J Respir Crit Care Med; 2005 Nov; 172(9):1105-11. PubMed ID: 16100014
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Airflow obstruction and exercise.
    Cooper CB
    Respir Med; 2009 Mar; 103(3):325-34. PubMed ID: 19071004
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Circulating visfatin in chronic obstructive pulmonary disease.
    Liu X; Ji Y; Chen J; Li S; Luo F
    Nutrition; 2009 Apr; 25(4):373-8. PubMed ID: 19056239
    [TBL] [Abstract][Full Text] [Related]  

  • 16. [New perspectives for respiratory rehabilitation in COPD].
    Fitting JW
    Rev Med Suisse; 2010 Nov; 6(272):2233-6, 2238-9. PubMed ID: 21207735
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Serum myostatin levels and skeletal muscle wasting in chronic obstructive pulmonary disease.
    Ju CR; Chen RC
    Respir Med; 2012 Jan; 106(1):102-8. PubMed ID: 21840694
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Systemic effects of COPD.
    Decramer M; De Benedetto F; Del Ponte A; Marinari S
    Respir Med; 2005 Dec; 99 Suppl B():S3-10. PubMed ID: 16219454
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Muscle and blood redox status after exercise training in severe COPD patients.
    Rodriguez DA; Kalko S; Puig-Vilanova E; Perez-Olabarría M; Falciani F; Gea J; Cascante M; Barreiro E; Roca J
    Free Radic Biol Med; 2012 Jan; 52(1):88-94. PubMed ID: 22064359
    [TBL] [Abstract][Full Text] [Related]  

  • 20. The value of C-reactive protein as a marker of systemic inflammation in stable chronic obstructive pulmonary disease.
    Karadag F; Kirdar S; Karul AB; Ceylan E
    Eur J Intern Med; 2008 Mar; 19(2):104-8. PubMed ID: 18249305
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 19.